Journal of Shandong University (Health Sciences) ›› 2020, Vol. 58 ›› Issue (9): 58-63.doi: 10.6040/j.issn.1671-7554.0.2020.137

Previous Articles     Next Articles

Correlation between interleukin-18 single nucleotide polymorphism and susceptibility of laryngeal squamous cell carcinoma: a report of 73 cases

MENG Zhaotun1, LI Qin2, SUN Hui3, WU Xinfang4, SUN Wenkai4, GAO Wei5   

  1. 1. Medical Department, Qingdao University, Qingdao 266071, Shandong, China;
    2. Department of Otorhinolaryngology, Linyi Peoples Hospital, Linyi 276000, Shandong, China;
    3. Weifang Clinical Medical College, Weifang Medical University, Weifang 261053, Shandong, China;
    4. School of Clinical Medicine, Binzhou Medical University, Binzhou 256603, Shandong, China;
    5. Graduate School, Shandong First Medical University, Taian 271016, Shandong, China
  • Online:2020-09-10 Published:2020-08-30

PDF (PC)

294

Abstract: Objective To investigate the correlation between interleukin-18(IL-18)and promotors -137G/C and -607C/A gene polymorphisms and the susceptibility of laryngeal squamous cell carcinoma(LSCC)in a Chinese Han population in Shandong Province. Methods A total of 73 LSCC patients(case group)treated at Linyi Peoples Hospital during May 2017 and Oct. 2019 and 73 healthy controls were enrolled. The clinical information and peripheral venous blood samples(2 mL)were collected. The whole blood DNA was extracted, and gene sequencing and SNP genotyping 山 东 大 学 学 报 (医 学 版)58卷9期 -孟朝暾,等.白细胞介素18单核苷酸多态性与73例喉鳞状细胞癌易感性的关联性 \=-were conducted. The quantitative data were analyzed with Students-t test, and the qualitative data were analyzed with Pearson χ2 test or Fisher exact test. The control group was analyzed with chi-square goodness of fit test to verify whether it was in accordance with the Hardy-Weinberg equilibrium law. The correlation between two SNP loci and risk factors(age, smoking, drinking)with LSCC risk was determined with binary Logistic regression analysis. Results The case group had higher genotype frequency of GC at -137G/C(34.2% vs 19.2%, P=0.040), but there was no significant difference in the genotype frequency at -607C/A between the two groups(P>0.05). Smoking and drinking increased the risk of LSCC(OR=5.710; 3.116). After the risk factors of genotype, age, smoking and drinking history were adjusted, the OR of LSCC risk in smokers and -137G/C carriers were 4.967(95%CI=2.185-11.289, P<0.001)and 2.971(95%CI=1.243-7.101, P=0.014), respectively. Conclusion Our findings suggest that IL-18 promoter -137G/C polymorphism is correlated with an increased risk of LSCC.

Key words: Laryngeal squamous cell carcinoma, Single nucleotide polymorphism, Interleukins-18, Susceptibility, Risk factor

CLC Number: 

  • R767
[1] Rudolph E, Dyckhoff G, Becher H, et al. Effects of tumour stage, comorbidity and therapy on survival of laryngeal cancer patients: a systematic review and a meta-analysis[J]. Eur Arch Otorhinolaryngol, 2011, 268(2): 165-179.
[2] Marioni G, Marchese-Ragona R, Cartei G, et al. Current opinion in diagnosis and treatment of laryngeal carcinoma[J]. Cancer Treat Rev, 2006, 32(7): 504-515.
[3] Markou K, Christoforidou A, Karasmanis I, et al. Laryngeal cancer: epidemiological data from Nuorthern Greece and review of the literature[J]. Hippokratia, 2013, 17(4): 313-318.
[4] 中华耳鼻咽喉头颈外科杂志编辑委员会头颈外科组, 中华医学会耳鼻咽喉头颈外科学分会头颈学组,李晓明. 喉癌外科手术及综合治疗专家共识[J]. 中华耳鼻咽喉头颈外科杂志, 2014, 49(8): 620-626.
[5] Hah JH, Sim S, An SY, et al. Evaluation of the prevalence of and factors associated with laryngeal diseases among the general population[J]. Laryngoscope, 2015, 125(11): 2536-2542.
[6] Islami F, Tramacere I, Rota M, et al. Alcohol drinking and laryngeal cancer: overall and dose-risk relation—a systematic review and meta-analysis[J]. Oral Oncol, 2010, 46(11): 802-810.
[7] Si FZ, Feng YQ, Han M. Association between interleukin-17 gene polymorphisms and the risk of laryngeal cancer in a Chinese population[J]. Genet Mol Res, 2017, 16(1). doi: 10.4238/gmr16019076.
[8] Su J, Cui J, Xue HT, et al. Study on the correlation between CD14 gene polymorphism and susceptibility to laryngeal cancer[J]. Eur Rev Med Pharmacol Sci, 2017, 21(19): 4292-4297.
[9] Vijay PR, Kumar R, Bhatt M, et al. To investigate the affiliation of XRCC-1 Gene Arg194Trp polymorphism in alcohol and tobacco substance users and loco-regionally progressed Laryngeal squamous cell carcinoma[J]. J Oral Biol Craniofac Res, 2019, 9(1): 77-80.
[10] 李大鹏, 黄辉, 柴伟, 等. hOGG1基因多态性与喉癌易感性的相关性分析[J]. 中华耳鼻咽喉头颈外科杂志, 2016, 51(9): 681-684. LI Dapeng, HUANG Hui, CHAI Wei, et al. Analysis of association of human 8-oxoguanine giycosylase 1 polymorphism with the susceptibility of laryngeal cancer[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2016, 51(9): 681-684.
[11] Nolan KF, Greaves DR, Waldmann H. The human interleukin 18 gene IL18 maps to 11q22.2-q22.3, closely linked to the DRD2 gene locus and distinct from mapped IDDM loci[J]. Genomics, 1998, 51(1): 161-163.
[12] Back LK, Farias TD, Da CP, et al. Functional polymorphisms of interleukin-18 gene and risk of breast cancer in a Brazilian population[J]. Tissue Antigens, 2014, 84(2): 229-233.
[13] Dwivedi S, Goel A, Mandhani A, et al. Functional genetic variability at promoters of pro-(IL-18)and anti-(IL-10)inflammatory affects their mRNA expression and survival in prostate carcinoma patients: Five year follow-up study[J]. Prostate, 2015, 75(15): 1737-1746.
[14] Chang WS, Shen TC, Yeh WL, et al. Contribution of inflammatory cytokine interleukin-18 genotypes to renal cell carcinoma[J]. Int J Mol Sci, 2019, 20(7): 1563.
[15] 樊春波, 王晶, 蒋勇, 等. ApoE和IL-18基因多态性与脑胶质瘤发生的临床关系[J]. 基因组学与应用生物学, 2018, 37(10): 4574-4580. FAN Chunbo, WANG Jing, JIANG Yong, et al. The clinical relationship between ApoE and IL-18 gene polymorphism and brain glioma[J]. Genomics and Applied Biology, 2018, 37(10): 4574-4580.
[16] Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM[J]. Ann Surg Oncol, 2010, 17(6): 1471-1474.
[17] Zhou J, Zhang D, Zhou L, et al. Association of the recurrence and canceration rate of vocal leukoplakia with interleukin-10 promoter variants over a 2-year period[J]. Acta Otolaryngol, 2016, 136(11): 1147-1153.
[18] 麦家豪, 马玲国. 人乳头状瘤病毒与喉癌的相关性研究现状[J]. 中华耳鼻咽喉头颈外科杂志, 2019, 54(5): 385-388. MAI Jiahao, MA Lingguo. Human papillomavirus and laryngeal cancer[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2019, 54(5): 385-388.
[19] Fang R, Huang Y, Xie J, et al. Downregulation of miR-29c-3p is associated with a poor prognosis in patients with laryngeal squamous cell carcinoma[J]. Diagn Pathol, 2019, 14(1): 109.
[20] 李钦, 王凌荣, 陈彦林, 等. 谷胱苷肽S转移酶M1和T1基因多态性与喉及下咽癌易感性的关系[J]. 临床耳鼻咽喉头颈外科杂志, 2009, 23(24): 1105-1107. LI Qin, WANG Lingrong, CHEN Yanlin, et al. Polymorphisms of GSTM1, GSTT1 and susceptibility of laryngeal and hypopharyngeal carcinomas[J]. Journal of Clinical Otorhinolaryngology, 2009, 23(24): 1105-1107.
[21] Bakr NM, Awad A, Moustafa EA. Association of genetic variants in the interleukin-18 gene promoter with risk of hepatocellular carcinoma and metastasis in patients with hepatitis C virus infection[J]. IUBMB Life, 2018, 70(2): 165-174.
[22] Gunel N, Coskun U, Sancak B, et al. Clinical importance of serum interleukin-18 and nitric oxide activities in breast carcinoma patients[J]. Cancer, 2002, 95(3): 663-667.
[23] Farhat K, Hassen E, Bouzgarrou N, et al. Functional IL-18 promoter gene polymorphisms in Tunisian nasopharyngeal carcinoma patients[J]. Cytokine, 2008, 43(2): 132-137.
[24] Martone T, Bellone G, Pagano M, et al. Constitutive expression of interleukin-18 in head and neck squamous carcinoma cells[J]. Head Neck, 2004, 26(6): 494-503.
[25] Giedraitis V, He B, Huang WX, et al. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation[J]. J Neuroimmunol, 2001, 112(1-2): 146-152.
[26] Li X, Ren D, Li Y, et al. Increased cancer risk associated with the -607C/A polymorphism in interleukin-18 gene promoter: an updated meta-analysis including 12,502 subjects[J]. J BUON, 2015, 20(3): 902-917.
[27] Asefi V, Mojtahedi Z, Khademi B, et al. Head and neck squamous cell carcinoma is not associated with interleukin-18 promoter gene polymorphisms: a case-control study[J]. J Laryngol Otol, 2009, 123(4): 444-448.
[28] Jurecekova J, Babusikova E, Kmetova SM, et al. Association between interleukin-18 variants and prostate cancer in Slovak population[J]. Neoplasma, 2017, 64(1): 148-155.
[29] Nong LG, Luo B, Zhang L, et al. Interleukin-18 gene promoter polymorphism and the risk of nasopharyngeal carcinoma in a Chinese population[J]. DNA Cell Biol, 2009, 28(10): 507-513.
[30] Singh PK, Ahmad MK, Kumar V, et al. Effects of interleukin-18 promoter(C607A and G137C)gene polymorphisms and their association with oral squamous cell carcinoma(OSCC)in northern India[J]. Tumour Biol, 2014, 35(12): 12275-12284.
[31] 杨丽娟, 温树信, 林佳, 等. CD14启动子区遗传变异对喉癌遗传易感性的影响[J]. 中华耳鼻咽喉头颈外科杂志, 2016, 51(3): 197-202. YANG Lijuan, WEN Shuxin, LIN Jia, et al. Effect of CD14 promoter variants on the susceptibility to laryngeal cancer[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2016, 51(3): 197-202.
No related articles found!
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd